SGLT2 Inhibitors and Fall Risk in Type 2 Diabetes Patients

New study highlights increased fall risk with diabetes drugs, especially when SGLT2 inhibitors are combined with GLP-1 RAs

Topline
In people with type 2 diabetes, the use of SGLT2 inhibitors is independently linked to higher risk of falls and that risk rises further when combined with GLP-1 receptor agonists, according to a prospective study from Japan.

Study Details
Type 2 diabetes (T2D) is known to increase fall risk due to complications like peripheral neuropathy and hypogl…